UBS Group »

Bright Minds Biosciences shares owned by UBS Group

Quarter-by-quarter ownership of Bright Minds Biosciences (DRUG) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Bright Minds Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Bright Minds Biosciences held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bright Minds Biosciences by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $889 622 1.43

More positions owned by UBS Group

Microsoft Corporation (MSFT)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
NVIDIA Corporation (NVDA)
Ubs Group SHS (UBS)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Union Pacific Corporation (UNP)
Alphabet Cap Stk Cl C Put Option (GOOG)
Meta Platforms Cl A (META)

View all positions for UBS Group

Top funds holding Bright Minds Biosciences

Hrt Financial
Virtu Financial
UBS Group
Royal Bank of Canada
Aspire Private Capital

View all funds holding Bright Minds Biosciences